Cargando…

Knockdown of RAI14 suppresses the progression of gastric cancer

BACKGROUND: Retinoic acid induced 14 (RAI14), also known as NORPEG, is reported as being deregulated in non-small-cell lung cancer, together with having involvement in its cell proliferation as a super enhancer related gene. PURPOSE: The objective of this study was to investigate the role of RAI14 i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cheng, Maimaiti, Aihemaiti, Zhang, Xin, Qu, Hui, Sun, Qilong, He, Qingsi, Yu, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186306/
https://www.ncbi.nlm.nih.gov/pubmed/30349303
http://dx.doi.org/10.2147/OTT.S175502
_version_ 1783362836399915008
author Chen, Cheng
Maimaiti, Aihemaiti
Zhang, Xin
Qu, Hui
Sun, Qilong
He, Qingsi
Yu, Wenbin
author_facet Chen, Cheng
Maimaiti, Aihemaiti
Zhang, Xin
Qu, Hui
Sun, Qilong
He, Qingsi
Yu, Wenbin
author_sort Chen, Cheng
collection PubMed
description BACKGROUND: Retinoic acid induced 14 (RAI14), also known as NORPEG, is reported as being deregulated in non-small-cell lung cancer, together with having involvement in its cell proliferation as a super enhancer related gene. PURPOSE: The objective of this study was to investigate the role of RAI14 in the progression and metastasis of gastric cancer and explore the associated mechanism. MATERIALS AND METHODS: GEPIA database was used to analyze the expression of RAI14 in gastric cancer. MNK45 and AGS cells were transfected with siRNA-RAI14 to block the expression of RAI14. Cell Counting Kit 8 and colony formation assays were performed to measure cell proliferation. Cell migration and invasion capacities was examined by transwell assay. Apoptosis rate was detected using flow cytometry, and the protein levels of apoptosis-related proteins was determined using Western blot assay. Reverse-transcription PCR assay was used to detect the expressions of RAB31. RESULTS: Gene expression profiling interactive analysis revealed that RAI14 was substantially upregu-lated in gastric cancer and higher expression of RAI14 was associated with worse prognosis. We also observed that the knockdown of RAI14 by siRNA-RAI14 transfection suppressed growth capacity of MKN45 and AGS cells. Also, RAI14 knockdown inhibited migration and invasion of MKN45 and AGS cells in vitro. Moreover, RAI14 knockdown was observed to accelerate cell apoptosis via down-regulation of Bcl-2 and upregulation of Bax in MKN45 and AGS cells. Furthermore, downregulation of RAI14 inhibited the activation of Akt pathway, and activation of Akt by IGF-1 could restore the reduced proliferation induced by RAI14 knockdown. In addition, we found that RAI14 had a positive correlation with the RAB31 in gastric cancer by GEPIA reverse-transcription PCR and Western blot assays, and the reduced proliferation caused by RAI14 knockdown was restored by RAB31. CONCLUSION: RAI14 knockdown inhibited proliferation, migration and invasion and promoted apoptosis by downregulating the Akt pathway in gastric cancer cells, and RAB31 might be a downstream target gene of RAI14, providing a novel sight into the molecular mechanism of RAI14 and a potential target for gastric cancer treatment.
format Online
Article
Text
id pubmed-6186306
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61863062018-10-22 Knockdown of RAI14 suppresses the progression of gastric cancer Chen, Cheng Maimaiti, Aihemaiti Zhang, Xin Qu, Hui Sun, Qilong He, Qingsi Yu, Wenbin Onco Targets Ther Original Research BACKGROUND: Retinoic acid induced 14 (RAI14), also known as NORPEG, is reported as being deregulated in non-small-cell lung cancer, together with having involvement in its cell proliferation as a super enhancer related gene. PURPOSE: The objective of this study was to investigate the role of RAI14 in the progression and metastasis of gastric cancer and explore the associated mechanism. MATERIALS AND METHODS: GEPIA database was used to analyze the expression of RAI14 in gastric cancer. MNK45 and AGS cells were transfected with siRNA-RAI14 to block the expression of RAI14. Cell Counting Kit 8 and colony formation assays were performed to measure cell proliferation. Cell migration and invasion capacities was examined by transwell assay. Apoptosis rate was detected using flow cytometry, and the protein levels of apoptosis-related proteins was determined using Western blot assay. Reverse-transcription PCR assay was used to detect the expressions of RAB31. RESULTS: Gene expression profiling interactive analysis revealed that RAI14 was substantially upregu-lated in gastric cancer and higher expression of RAI14 was associated with worse prognosis. We also observed that the knockdown of RAI14 by siRNA-RAI14 transfection suppressed growth capacity of MKN45 and AGS cells. Also, RAI14 knockdown inhibited migration and invasion of MKN45 and AGS cells in vitro. Moreover, RAI14 knockdown was observed to accelerate cell apoptosis via down-regulation of Bcl-2 and upregulation of Bax in MKN45 and AGS cells. Furthermore, downregulation of RAI14 inhibited the activation of Akt pathway, and activation of Akt by IGF-1 could restore the reduced proliferation induced by RAI14 knockdown. In addition, we found that RAI14 had a positive correlation with the RAB31 in gastric cancer by GEPIA reverse-transcription PCR and Western blot assays, and the reduced proliferation caused by RAI14 knockdown was restored by RAB31. CONCLUSION: RAI14 knockdown inhibited proliferation, migration and invasion and promoted apoptosis by downregulating the Akt pathway in gastric cancer cells, and RAB31 might be a downstream target gene of RAI14, providing a novel sight into the molecular mechanism of RAI14 and a potential target for gastric cancer treatment. Dove Medical Press 2018-10-09 /pmc/articles/PMC6186306/ /pubmed/30349303 http://dx.doi.org/10.2147/OTT.S175502 Text en © 2018 Chen et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Chen, Cheng
Maimaiti, Aihemaiti
Zhang, Xin
Qu, Hui
Sun, Qilong
He, Qingsi
Yu, Wenbin
Knockdown of RAI14 suppresses the progression of gastric cancer
title Knockdown of RAI14 suppresses the progression of gastric cancer
title_full Knockdown of RAI14 suppresses the progression of gastric cancer
title_fullStr Knockdown of RAI14 suppresses the progression of gastric cancer
title_full_unstemmed Knockdown of RAI14 suppresses the progression of gastric cancer
title_short Knockdown of RAI14 suppresses the progression of gastric cancer
title_sort knockdown of rai14 suppresses the progression of gastric cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186306/
https://www.ncbi.nlm.nih.gov/pubmed/30349303
http://dx.doi.org/10.2147/OTT.S175502
work_keys_str_mv AT chencheng knockdownofrai14suppressestheprogressionofgastriccancer
AT maimaitiaihemaiti knockdownofrai14suppressestheprogressionofgastriccancer
AT zhangxin knockdownofrai14suppressestheprogressionofgastriccancer
AT quhui knockdownofrai14suppressestheprogressionofgastriccancer
AT sunqilong knockdownofrai14suppressestheprogressionofgastriccancer
AT heqingsi knockdownofrai14suppressestheprogressionofgastriccancer
AT yuwenbin knockdownofrai14suppressestheprogressionofgastriccancer